BPGbio, a clinical-stage biopharmaceutical company, has published preclinical research in the Journal of Medicinal Chemistry on Compound 40, an experimental small molecule aimed at glioma, including BPGbio Reports Brain-Penetrant Glioma Candidate Shows Preclinical Tumor ControlRead more